Development of generic gliclazide 60 mg modified release tablets using central composite design
A modified release gliclazide 60 mg tablet using Methocel® K100 Premium LV DC2 as a drug retaining polymer was prepared by direct compression. Central composite design was adopted for formulation optimization. The two independent formulation variables included the amount of Methocel® K100 LV DC2...
Saved in:
| Main Authors: | , , |
|---|---|
| 格式: | Article |
| 语言: | English |
| 出版: |
College of Pharmacists of Buenos Aires Province, Argentina
2015
|
| 主题: | |
| 在线阅读: | http://irep.iium.edu.my/44848/1/Latin_American_Journal_of_Pharmacy_34_8_page_1516.pdf http://irep.iium.edu.my/44848/ http://www.latamjpharm.org/ |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|